Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of IDN-6556 in Subjects With Liver Cirrhosis

ClinicalTrials.gov ID: NCT02230670

Public ClinicalTrials.gov record NCT02230670. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Subjects With Liver Cirrhosis

Study identification

NCT ID
NCT02230670
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Conatus Pharmaceuticals Inc.
Industry
Enrollment
87 participants

Conditions and interventions

Interventions

  • IDN-6556 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2014
Primary completion
Dec 31, 2015
Completion
Dec 31, 2015
Last update posted
Jul 4, 2017

2014 – 2016

United States locations

U.S. sites
28
U.S. states
15
U.S. cities
24
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233
Scripps Clinic La Jolla California 92037
Loma Linda University Medical Center Loma Linda California 92354
Cedar-Sinai Medical Center Los Angeles California 90048
Univeristy of California, San Diego San Diego California 92093
California Pacific Medical Center San Francisco California 94115
University of Florida Gainesville Florida 32610
University of Miami Miami Florida 33136
Piedmont Atlanta Hospital Atlanta Georgia 30309
University of Chicago Chicago Illinois 60637
Loyola University Medical Cente Maywood Illinois 60153
Indiana University Indianapolis Indiana 46202
University of Louisville Louisville Kentucky 40202
Henry Ford Hospital Detroit Michigan 48202
Rutgers New Jersey Medical School Newark New Jersey 07103
North Shore University Hospital Manhasset New York 11030
NYU Medical Center New York New York 10016
Mt. Sinai School of Medicine New York New York 10029
University of Cincinnati Physicians Company, LLC Cincinnati Ohio 45267
University of Pennsylvania Philadelphia Pennsylvania 19104
Einstein Healthcare Network Philadelphia Pennsylvania 19141
Baylor All Saints Medical Center Fort Worth Texas 76104
Baylor College of Medicine Houston Texas 77030
Baylor St. Luke's Medical Center Houston Texas 77030
UT Health Science Center at Houston Houston Texas 77030
University of Utah Hospital Salt Lake City Utah 84132
Bon Secours Mary Immaculate Hospital Newport News Virginia 23602
Bon Secours St. Mary's Hospital of Richmond, Inc. Richmond Virginia 23226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02230670, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 4, 2017 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02230670 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →